Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATTEMPT: Dapagliflozin in adolescents with type 1 diabetes
NCT04333823Phase 3Unknown
- Sponsor
- SickKids
- Start
- Dec 2020
- Primary completion
- May 2024
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial of dapagliflozin in type 1 diabetes mellitus (T1D), sponsored by SickKids. Status: unknown.
02
Drugs
dapagliflozin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT04333823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04333823.